ethyl-3-hydroxy-8-methylnonanoic acid | 62675-78-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羟基酸及其衍生物
• 英文名称: ethyl-3-hydroxy-8-methylnonanoic acid
• 英文别名: 3-hydroxy-8-methylnonanoic acid
• CAS: 62675-78-9
• 化学式: C₁₀H₂₀O₃
• 分子量: 188.267
• InChiKey: UXJJZNZXKAPKLQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  13
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester
  申请人：——

  公开号：US20030225301A1

  公开（公告）日：2003-12-04

  A process for producing an optically active 3-azide-carboxylic acid ester by reacting an optically active 3-hydroxycarboxylic acid ester and a thionyl halide in the presence of a basic substance in an organic solvent to produce an optically active 3-halogenocarboxylic acid ester which is then reacted with an azide salt represented by the formula: MN 3 (wherein M is an alkaline metal) in water or a mixture of water and a water soluble organic solvent.

  通过在有机溶剂中，在碱性物质存在下，将光学活性的3-羟基羧酸酯和硫酰卤在一起反应，产生光学活性的3-卤代羧酸酯，然后将其与由公式表示的偶氮盐（其中M是碱性金属）在水或水和水溶性有机溶剂的混合物中反应，从而生产光学活性的3-偶氮基羧酸酯的方法。
• Antibiotic WAP-8294A, method for preparing the same and antibacterial composition
  申请人：Wakamoto Pharmaceutical Co., Ltd.

  公开号：EP0668358A1

  公开（公告）日：1995-08-23

  Antibiotics WAP-8294A, A1, A2, A4, AX, AX-8, AX-9 and AX-13 or pharmaceutically acceptable salts thereof produced by a strain belonging to the genus Lysobacter; a method for producing the foregoing antibiotic WAP-8294A comprising the steps of cultivating, in a culture medium, a microorganism belonging to the genus Lysobactor and having an ability of producing the antibiotic WAP-8294A to produce the antibiotic and accumulate it in the culture medium; then recovering the antibiotic; as well as an antibacterial composition comprising the antibiotic or pharmaceutically acceptable salts thereof are herein disclosed. The novel antibiotic WAP-8294A has an excellent therapeutic effect on infectious diseases developed by infection with Gram-positive bacteria, in particular, MRSA and, therefore, the antibiotic is effective for treating diseases including MRSA infectious diseases developed through infection with Gram-positive bacteria as infectious bacteria.

  由溶菌属菌株产生的抗生素 WAP-8294A、A1、A2、A4、AX、AX-8、AX-9 和 AX-13 或其药学上可接受的盐；生产上述抗生素 WAP-8294A 的方法，包括以下步骤：在培养基中培养属于溶菌属并具有产生抗生素 WAP-8294A 能力的微生物，使其产生抗生素并在培养基中积累；然后回收抗生素；以及包含该抗生素或其药学上可接受的盐的抗菌组合物。新型抗生素 WAP-8294A 对因感染革兰氏阳性菌，特别是 MRSA 而引起的感染性疾病有很好的治疗效果，因此，该抗生素可有效治疗包括 MRSA 在内的疾病。 等革兰氏阳性菌感染的传染性疾病。
• Process for producing optically active 3-halogenocarboxylic acid esters and 3-azide-carboxylic acid esters
  申请人：Takasago International Corporation

  公开号：EP1344763A1

  公开（公告）日：2003-09-17

  A process for producing an optically active 3-azide-carboxylic acid ester by reacting an optically active 3-hydroxycarboxylic acid ester and a thionyl halide in the presence of a basic substance in an organic solvent to produce an optically active 3-halogenocarboxylic acid ester which is then reacted with an azide salt represented by the formula: MN3 (wherein M is an alkaline metal) in water or a mixture of water and a water soluble organic solvent.

  一种生产光学活性 3-叠氮羧酸酯的工艺，在有机溶剂中，在碱性物质存在下，使光学活性 3-羟基羧酸酯和硫酰基卤反应，生成光学活性 3-卤代羧酸酯，然后使其与式 MN3（其中 M 为碱金属）代表的叠氮盐反应：MN3（其中 M 为碱金属）在水或水与水溶性有机溶剂的混合物中反应。
• METHOD FOR PREPARING POLYLACTATE AND COPOLYMER THEREOF USING A MUTANT MICROORGANISM WITH ENHANCED POLYLACTATE, AND THE COPOLYMER PRODUCING CAPABILITY THEREOF
  申请人：LG Chem, Ltd.

  公开号：EP2314638A2

  公开（公告）日：2011-04-27

  Provided is a method of preparing polylactate (PLA) or a copolymer thereof using a mutant microorganism in which a gene participating in a coenzyme A (CoA) donor- and lactate-producing pathway is genetically manipulated to increase the productivity of a CoA donor and lactate. Amounts of the CoA donor and the lactate are simultaneously increased in a microbial metabolic pathway to enable effective biosynthesis of PLA and a hydroxyalkanoate-lactate copolymer having a high content of lactate, which is industrially useful.

  本发明提供了一种利用突变微生物制备聚乳酸（PLA）或其共聚物的方法，在这种突变微生物中，参与辅酶A（CoA）供体和乳酸盐产生途径的基因受到遗传操作，以提高CoA供体和乳酸盐的产量。在微生物代谢途径中，CoA 供体和乳酸盐的数量同时增加，从而能够有效地生物合成聚乳酸和具有高乳酸盐含量的羟基烷酸-乳酸盐共聚物，这在工业上是有用的。
• PREPARATION METHOD OF LACTATE POLYMERS AND LACTATE COPOLYMERS USING POLYHYDROXYALKANOATE SYNTHASE MUTANTS
  申请人：LG Chem, Ltd.

  公开号：EP2471910A2

  公开（公告）日：2012-07-04

  Mutants of various polyhydroxyalkanoate (PHA) synthases capable of synthesizing a lactate polymer (PLA) and a lactate copolymer (PLA copolymer), and a method of preparing a lactate polymer and a lactate copolymer using the same are provided. More specifically, a mutant of polyhydroxyalkanoate synthase set forth in SEQ ID NO: 2, 4, 6, or 8, and a method of preparing lactate polymer and lactate copolymer using the mutant of synthase are provided. The polyhydroxyalkanoate synthase set forth in SEQ ID NO: 2, 4, 6, or 8 can have an activity of synthesizing a lactate polymer and a lactate copolymer by an amino acid sequence mutation affecting an activity of synthesizing a lactate polymer, and can produce a lactate polymer and a copolymer that have different features, respectively, by using the mutants of the synthase.

  本发明提供了能够合成乳酸聚合物（聚乳酸）和乳酸共聚物（聚乳酸共聚物）的各种聚羟基烷酸（PHA）合酶的突变体，以及使用这些突变体制备乳酸聚合物和乳酸共聚物的方法。更具体地说，提供了 SEQ ID NO:2、4、6 或 8 所述的聚羟基烷酸合酶突变体，以及使用该合酶突变体制备乳酸聚合物和乳酸共聚物的方法。SEQ ID NO:2、4、6 或 8 所述的聚羟基烷酸合酶可通过影响合成乳酸聚合物活性的氨基酸序列突变而具有合成乳酸聚合物和乳酸共聚物的活性，并可通过使用该合酶的突变体生产分别具有不同特征的乳酸聚合物和共聚物。